Physician profile
William F Tucker
NPI 1124175286
$194,754.70
in general payments reported to CMS, 2019-2025
16 companies · $29K in 2025
The $29K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $42K · 2021: $33K · 2022: $18K · 2023: $31K · 2024: $22K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $74K · Consulting Fee: $6,300 · Travel and Lodging: $1,262 · Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $74,414.64 |
| Consulting Fee | $6,300.00 |
| Travel and Lodging | $1,261.94 |
| Food and Beverage | $844.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $189,504.89 | 2019-2025 | Trinity Dual Mobility, Apollo, Omnibotics 3.0 |
| Corin USA | $4,759.48 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $170.05 | 2021-2022 | |
| Baudax Bio INC. | $58.17 | 2021 | |
| Stryker Corporation | $46.43 | 2019-2024 | Augment Injectable |
| Zimmer Biomet Holdings, INC. | $28.79 | 2020 | |
| Smith+Nephew, INC. | $25.65 | 2019-2025 | Stravix |
| Sumitomo Pharma America, INC. | $24.87 | 2024 | Gemtesa |
| Bioventus LLC | $22.30 | 2024 | Durolane |
| Pfizer INC. | $22.28 | 2020 | |
| Medtronic, INC. | $20.61 | 2025 | Rapidvac |
| Medtronic USA, INC. | $17.48 | 2019 | |
| Theragen, INC. | $15.00 | 2022 | |
| Ethicon US, LLC | $14.15 | 2020 | |
| Ossur Americas, INC. | $13.50 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$22,241.14 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.